Source link : https://www.newshealth.biz/health-news/sglt2-inhibitor-reduces-risk-for-dementia-alzheimers-in-t2d/
MADRID — Patients with type 2 diabetes treated with sodium-glucose cotransporter 2 inhibitors (SGLT2is) show significant reductions in the risk of developing neurodegenerative disorders including Alzheimer’s disease, vascular dementia, and Parkinson’s disease, compared with those treated with other antidiabetic drugs, results from a large population-based cohort show. “This was the largest nationwide population-based longitudinal cohort […]
Author : News Health
Publish date : 2024-09-13 08:26:29
Copyright for syndicated content belongs to the linked Source.
Categories